Venture Certified
| 연구개발유형 | 2023-04-19 ~ 2026-04-18 | 20230420020017 | 2023-04-19 |
Revenue CAGR +164.4%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 10.0B | 3.8B | 1.4B |
| Operating Profit | -33.1B | -31.8B | -25.9B |
| Net Profit | -42.4B | -48.9B | -40.9B |
| Total Assets | 228.4B | 258.7B | 275.8B |
| Total Liabilities | 77.6B | 70.5B | 189.4B |
| Total Equity | 150.8B | 188.2B | 86.4B |
Operating Loss: Op. profit -33B
3 Consecutive Years of Net Loss
Debt Ratio Surge (+14pp YoY)
▲ 281.4%
▼ 14.9%
▲ 74.9%
▼ 59.9%
▲ 23.4%
| Name | Position | Role |
|---|---|---|
| 정광호 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "강원도 강릉시",
"ceo_name": "정광호",
"certificate": [
{
"cert_number": "20230420020017",
"changes": "",
"disclosure_date": "2023-04-20",
"first_cert_date": "2023-04-19",
"no": "1",
"type": "연구개발유형",
"valid_period": "2023-04-19 ~ 2026-04-18"
}
],
"company_name": "(주) 옵트바이오",
"corp_no": "141111-*******",
"financials": {
"2022": {
"capital_stock": 100000000,
"cost_of_sales": 60640000,
"current_assets": 3794944000,
"current_liabilities": 17101134000,
"gross_profit": 81934000,
"net_income": -4091705000,
"net_income_bs": -4092718000,
"non_current_assets": 23782892000,
"non_current_liabilities": 1839419000,
"non_operating_expenses": 1547058000,
"non_operating_income": 46358000,
"operating_profit": -2591005000,
"revenue": 142574000,
"sga_expenses": 2672939000,
"total_assets": 27577836000,
"total_equity": 8637283000,
"total_liabilities": 18940553000
},
"2023": {
"capital_stock": 14088655000,
"cost_of_sales": 123321000,
"current_assets": 2780928000,
"current_liabilities": 4895824000,
"gross_profit": 256591000,
"net_income": -4887293000,
"net_income_bs": -4887293000,
"non_current_assets": 23084358000,
"non_current_liabilities": 2150556000,
"non_operating_expenses": 1767294000,
"non_operating_income": 55517000,
"operating_profit": -3175516000,
"revenue": 379912000,
"sga_expenses": 3432107000,
"total_assets": 25865286000,
"total_equity": 18818906000,
"total_liabilities": 7046380000
},
"2024": {
"capital_stock": 14351810000,
"cost_of_sales": 833031000,
"current_assets": 1599415000,
"current_liabilities": 5191770000,
"gross_profit": 163474000,
"net_income": -4235460000,
"net_income_bs": -4235460000,
"non_current_assets": 21240796000,
"non_current_liabilities": 2565000000,
"non_operating_expenses": 961082000,
"non_operating_income": 37854000,
"operating_profit": -3312232000,
"revenue": 996505000,
"sga_expenses": 3475706000,
"total_assets": 22840211000,
"total_equity": 15083441000,
"total_liabilities": 7756770000
}
},
"industry": "화장품 제조업",
"investment": [],
"main_products": "화장품 소재",
"phone": "070-4195-****",
"years": [
2024,
2023,
2022
]
}